ONPATTRO® (patisiran) - RNAi Therapy
Select below to explore educational, scientific and clinical resources related to the licensed uses of our therapies in the UK
ONPATTRO® (patisiran)
View Prescribing InformationExplore clinical and educational resources related to the use of patisiran in adult patients hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) with stage 1 or stage 2 polyneuropathy
